Ersoy, M. 2026. Can Immature Granulocytes Guide Chemotherapy Decisions in Later Lines of Therapy for HER2-Negative Breast Cancer?. The European Research Journal. 12, 1 (Jan. 2026), 86–96. DOI:https://doi.org/10.18621/eurj.1764519.